Literature DB >> 1651817

Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin. Evidence for two use-dependent binding sites.

M J Barber1, C F Starmer, A O Grant.   

Abstract

Cardiac toxicity is a frequent manifestation in amitriptyline overdose and is felt to be due, in part, to sodium channel blockade by the drug. Another agent with sodium channel blocking properties, diphenylhydantoin, has been used clinically to reverse cardiac conduction abnormalities induced by amitriptyline. This reversal of toxicity is believed to occur secondary to competition for the sodium channel binding site. We evaluated individually and in combination the effects of amitriptyline (0.4 microM) and diphenylhydantoin (10-80 microM) on the sodium current in isolated rabbit atrial and ventricular myocytes at 17 degrees C. Using the whole-cell variant of the patch-clamp technique, we found that both amitriptyline and diphenylhydantoin reduced the sodium current in a use-dependent fashion. The time constant of recovery (tau r) from block by amitriptyline at -130 mV was very slow (13.6 +/- 3.2 seconds), whereas tau r during diphenylhydantoin exposure was fast (0.71 +/- 0.21 seconds, p less than 0.0001 compared with amitriptyline). During exposure of cells to a mixture of the two drugs, tau r was found to be 6.6 +/- 1.8 seconds, but no evidence of direct competition between amitriptyline and diphenylhydantoin was seen. Attempts to fit the recovery data of the mixture to two exponentials resulted in no significant improvement in the fit when compared with that using a single exponential. Use of the sodium channel blocking agent lidocaine (similar kinetics to diphenylhydantoin) in competition with amitriptyline resulted in findings consistent with direct competition of these two drugs for a single binding site. These observations prompted us to evaluate the possibility that diphenylhydantoin was not acting at (and therefore not competing for) the same channel binding site as amitriptyline. Experiments altering pHi and pHo revealed dramatic differences between amitriptyline and diphenylhydantoin. When pHo was increased from 7.4 to 8.0, tau r was reduced approximately threefold (from 13.6 +/- 3.2 to 4.2 +/- 0.1 seconds, p less than 0.0001) during exposure to amitriptyline, but no effect was seen on tau r after exposure to diphenylhydantoin. Conversely, when pHi was increased from 7.3 to 8.0, tau r after amitriptyline was unaffected, but tau r after diphenylhydantoin markedly increased (from 0.71 +/- 0.21 to 2.60 +/- 1.30 seconds, p less than 0.001). Additionally, diphenylhydantoin block demonstrated profound voltage dependence across the range of -130 to -90 mV, whereas amitriptyline block appeared less voltage sensitive. Single-channel studies using patch-clamp techniques in isolated ventricular myocytes supported these data.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651817     DOI: 10.1161/01.res.69.3.677

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

1.  Small-cell lung cancer (human): potentiation of endocytic membrane activity by voltage-gated Na(+) channel expression in vitro.

Authors:  P U Onganer; M B A Djamgoz
Journal:  J Membr Biol       Date:  2005-03       Impact factor: 1.843

Review 2.  Antidepressants as analgesics.

Authors:  Gary McCleane
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 3.  Sodium channel blockers for the treatment of neuropathic pain.

Authors:  Anindya Bhattacharya; Alan D Wickenden; Sandra R Chaplan
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

Review 4.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Ionic and cellular mechanisms underlying the development of acquired Brugada syndrome in patients treated with antidepressants.

Authors:  Yoshino Minoura; José M Di Diego; Hector Barajas-Martínez; Andrew C Zygmunt; Dan Hu; Serge Sicouri; Charles Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2011-10-28

6.  Antidepressants inhibit Nav1.3, Nav1.7, and Nav1.8 neuronal voltage-gated sodium channels more potently than Nav1.2 and Nav1.6 channels expressed in Xenopus oocytes.

Authors:  Takafumi Horishita; Nobuyuki Yanagihara; Susumu Ueno; Dan Okura; Reiko Horishita; Tomoko Minami; Yuichi Ogata; Yuka Sudo; Yasuhito Uezono; Takeyoshi Sata; Takashi Kawasaki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-09-14       Impact factor: 3.000

Review 7.  Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest.

Authors:  Serge Sicouri; Charles Antzelevitch
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

8.  Cellular electrophysiology of canine pulmonary vein cardiomyocytes: action potential and ionic current properties.

Authors:  Joachim R Ehrlich; Tae-Joon Cha; Liming Zhang; Denis Chartier; Peter Melnyk; Stefan H Hohnloser; Stanley Nattel
Journal:  J Physiol       Date:  2003-07-07       Impact factor: 5.182

Review 9.  Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns?

Authors:  Pal Pacher; Valeria Kecskemeti
Journal:  Curr Pharm Des       Date:  2004       Impact factor: 3.116

10.  Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.

Authors:  Jingyao Liang; Xiaoyan Liu; Meiyan Pan; Wei Dai; Zhao Dong; Xiaolin Wang; Ruozhuo Liu; Jianquan Zheng; Shengyuan Yu
Journal:  Neuromolecular Med       Date:  2013-11-30       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.